ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Aclarion Inc

Aclarion Inc (ACON)

0,1757
0,0006
(0,34%)
Beim Schlusskurs: 27 September 10:00PM
0,1757
0,00
( 0,00% )
Nach Börsenschluss: 10:06PM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,1757
Gebot
0,1758
Fragen
0,1781
Volumen
107.641
0,1751 Tagesbereich 0,185
0,1599 52-Wochen-Bereich 9,9008
Marktkapitalisierung
Handelsende
0,1751
Handelsbeginn
0,185
Letzte Trade
243
@
0.1758
Letzter Handelszeitpunkt
22:00:00
Finanzvolumen
US$ 19.036
VWAP
0,176845
Durchschnittliches Volumen (3 Mio.)
518.040
Ausgegebene Aktien
9.610.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,35
Gewinn pro Aktie (EPS)
-0,51
Erlöse
75k
Nettogewinn
-4,91M

Über Aclarion Inc

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments.

Sektor
Medical Laboratories
Branche
Medical Laboratories
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Aclarion Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker ACON. The last closing price for Aclarion was US$0,18. Over the last year, Aclarion shares have traded in a share price range of US$ 0,1599 to US$ 9,9008.

Aclarion currently has 9.610.000 shares in issue. The market capitalisation of Aclarion is US$1,68 million. Aclarion has a price to earnings ratio (PE ratio) of -0.35.

ACON Neueste Nachrichten

Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

Modic Changes (MC) are MRI Findings Associated With Endplate Damage, Neoinnervation, and Chronic Low Back Pain (cLBP) MR Spectroscopy (MRS) Measurement of Intradiscal Propionic Acid (PA) can...

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView presents an exclusive Q&A with Brent Ness, CEO and Director of Aclarion, Inc. (Nasdaq: ACON). As a disruptive healthcare...

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

Successful milestones achieved and upcoming include peer-reviewed publications, commercial agreements, and payer coverage decisions Progressing with proven path toward standard of care addressing...

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment Response LIFEHAB is a Randomized Controlled...

Aclarion Added to PRISM Emerging Medical Devices Index

Company's industry-first technology addresses chronic low back painAclarion secured its first commercial agreement with Michigan's Sheridan Community HospitalPRISM Emerging Medical Devices Index...

Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation Market

Justin Kubeck, M.D. of Ocean Pain and Spine in Toms River, NJ Will Lead a Statewide Network of Providers That Use Nociscan to Better Serve This Important Segment of Low Back Pain Population...

Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

CLUE is a Multi-center Trial to Identify how Often Nociscan’s AI Data Changes the Initial Treatment Plan for Patients With Chronic Low Back Pain Dr. Justin Kubeck Will Initiate CLUE in New Jersey...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0113-6.042780748660.1870.18980.1731538820.17661101CS
4-0.0438-19.95444191340.21950.22220.15995773900.1811695CS
12-0.1113-38.78048780490.2870.34590.15995180400.23119891CS
26-0.1509-46.20330679730.32660.690.159914665530.35002943CS
52-5.4243-96.86255.69.90080.159915546141.95078282CS
156-46.2243-99.621336206946.464.80.1599106716110.40170131CS
260-46.2243-99.621336206946.464.80.1599106716110.40170131CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ZCMDZhongchao Inc
US$ 2,09
(55,39%)
1,74M
GIFTRDE Inc
US$ 2,28
(20,00%)
503
LDTCLeddarTech Holdings Inc
US$ 0,365
(14,06%)
245,22k
BAOSBaosheng Media Group Holdings Ltd
US$ 2,77
(10,80%)
10,33k
SNALSnail Inc
US$ 0,814
(7,66%)
725
QHQuhuo Ltd
US$ 1,21
(-13,45%)
2,25k
SYTSYLA Technologies Company Ltd
US$ 1,68
(-9,68%)
4,87k
WAVEEco Wave Power Global AB
US$ 4,30
(-9,28%)
239
GANXGain Therapeutics Inc
US$ 1,8001
(-9,09%)
115
TAOPTaoping Inc BVI
US$ 0,72
(-8,86%)
6,71k
NVDANVIDIA Corporation
US$ 121,05
(-0,29%)
2,01M
ZCMDZhongchao Inc
US$ 2,09
(55,39%)
1,74M
VCITVanguard Intermediate Term Corporate Bond
US$ 83,95
(0,01%)
1,67M
RIOTRiot Platforms Inc
US$ 7,79
(-0,64%)
1,04M
TLTiShares 20 plus Year Treasury Bond
US$ 98,39
(-0,17%)
1,03M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock